Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

587 Articles

Jon C. Ogg | Dec 11, 2012 at 2:53 PM EST

Teva Fails To Impress At Its Investor Meeting, Restructuring Awaits

ThinkstockTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) is not getting any great warm welcome out of its 2012 investor meeting webcast.…

Paul Ausick | Nov 30, 2012 at 4:05 PM EST

24/7 Wall St. Closing Bell — November 30, 2012: Market Wobbles to Lower Finish (COP, CAG, DUK, BMY, WPI, AVGO, OVTI, YOKU, ZUMZ, SOL, WWAV, LDK, VRSN, ZNGA, FB, GRPN)

U.S. equity markets opened mixed this morning, but some initial enthusiasm wore off by mid-morning and stocks moved slightly lower…

Jon C. Ogg | Nov 30, 2012 at 8:23 AM EST

Top Analyst Upgrades and Downgrades (ACTV, AGN, BMY, CAG, COP, DUK, LLY, FRX, MRK, PFE, TIF, ULTA, WPI, YUM)

These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Friday. Active…

Paul Ausick | Sep 25, 2012 at 12:06 PM EDT

No News is Good News — Peregrine Pharma

Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) fell about 80% yesterday after the company revealed that there were discrepancies in the data…

Jon C. Ogg | Sep 13, 2012 at 9:06 AM EDT

Vical Scores Big License Pact with Bristol-Myers Squibb

Vical Inc. (NASDAQ: VICL) is seeing its shares surging higher on news that it has signed a worldwide, nonexclusive licensing…

Jon C. Ogg | Sep 11, 2012 at 8:23 AM EDT

Top Analyst Upgrades and Downgrades (AU, AAPL, AN, BNS, BMY, CI, CLNE, CMCSA, OFC, DNKN, GFI, HMY, ICE, JCI, JNJ, SQM, FINL, WPI, YELP)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday.…

Paul Ausick | Aug 24, 2012 at 4:04 PM EDT

24/7 Wall St. Closing Bell — August 24, 2012: Markets Up on Macro News (BMY, KMI, STX, CPB, SPLS, ARUN, BEBE, CRM, SCVL, SOL, MSG, MDGN, SVU, ADSK)

The three major U.S. stock indexes opened lower this morning but picked up some buying steam in the first hour…

Jon C. Ogg | Aug 24, 2012 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades (ANF, AEO, ADSK, BMY, BIP, CPB, DV, IDCC, KMI, MDCO, MRK, OTEX, PCYC, STX, SPLS, VHC)

Jon OggThese are the top analyst calls of upgrades, downgrades and initiations we have seen from Wall St.…

Jon C. Ogg | Aug 2, 2012 at 11:47 AM EDT

Gilead Options & New High In Stock Bring Hope For Further Upside

Gilead Sciences Inc. (NASDAQ: GILD) is seeing shares surge today on news that Bristol-Myers Squibb Co. (NYSE: BMY) has run…

Trey Thoelcke | Jul 25, 2012 at 8:11 AM EDT

Drug Giants Show Mixed Earnings (BMY, LLY)

Surging growth of its Cymbalta depression treatment helped Eli Lilly & Co. (NYSE: LLY) beat Wall St.’s earnings expectations. But…

Paul Ausick | Jul 18, 2012 at 10:56 AM EDT

Top 10 U.S. Drugs for 2012 First Quarter

Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for…

Paul Ausick | Jul 18, 2012 at 8:34 AM EDT

Abbott Labs Stung by Foreign Exchange Rate

Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but…

Jon C. Ogg | Jul 16, 2012 at 10:43 AM EDT

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to…

Jon C. Ogg | Jul 10, 2012 at 7:35 AM EDT

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks…

Jon C. Ogg | Jul 2, 2012 at 2:42 PM EDT

Which Biotechs Could Be Next M&A Targets (AMLN, BMY, VRTX, CELG, CBST, AMRN, BMRN, VVUS, ARNA, PCYC, AFFX, THRX, RIGL, HGSI, GSK, DNDN)

The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value…

1 … 29 30 31 32 33 … 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Teva Fails To Impress At Its Investor Meeting, Restructuring Awaits

24/7 Wall St. Closing Bell — November 30, 2012: Market Wobbles to Lower Finish (COP, CAG, DUK, BMY, WPI, AVGO, OVTI, YOKU, ZUMZ, SOL, WWAV, LDK, VRSN, ZNGA, FB, GRPN)

Top Analyst Upgrades and Downgrades (ACTV, AGN, BMY, CAG, COP, DUK, LLY, FRX, MRK, PFE, TIF, ULTA, WPI, YUM)

No News is Good News — Peregrine Pharma

Vical Scores Big License Pact with Bristol-Myers Squibb

Top Analyst Upgrades and Downgrades (AU, AAPL, AN, BNS, BMY, CI, CLNE, CMCSA, OFC, DNKN, GFI, HMY, ICE, JCI, JNJ, SQM, FINL, WPI, YELP)

24/7 Wall St. Closing Bell — August 24, 2012: Markets Up on Macro News (BMY, KMI, STX, CPB, SPLS, ARUN, BEBE, CRM, SCVL, SOL, MSG, MDGN, SVU, ADSK)

Top Analyst Upgrades and Downgrades (ANF, AEO, ADSK, BMY, BIP, CPB, DV, IDCC, KMI, MDCO, MRK, OTEX, PCYC, STX, SPLS, VHC)

Gilead Options & New High In Stock Bring Hope For Further Upside

Drug Giants Show Mixed Earnings (BMY, LLY)

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

Which Biotechs Could Be Next M&A Targets (AMLN, BMY, VRTX, CELG, CBST, AMRN, BMRN, VVUS, ARNA, PCYC, AFFX, THRX, RIGL, HGSI, GSK, DNDN)

Prediction: Pfizer Stock Will Double on This Date

SMH ETF Investors: Watch Hyperscaler Capex Guidance at July Earnings Calls

The Average American Has Worked for 6 Employers and 23% Still Have Multiple Old Retirement Accounts, Fidelity’s 2026 Study Finds

The Average American Has Worked for 6 Employers and 23% Still Have Multiple Old Retirement Accounts, Fidelity's 2026 Study Finds

Fidelity's 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

Prediction: Pfizer Stock Will Double on This Date

SMH ETF Investors: Watch Hyperscaler Capex Guidance at July Earnings Calls

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Teva Fails To Impress At Its Investor Meeting, Restructuring Awaits

24/7 Wall St. Closing Bell — November 30, 2012: Market Wobbles to Lower Finish (COP, CAG, DUK, BMY, WPI, AVGO, OVTI, YOKU, ZUMZ, SOL, WWAV, LDK, VRSN, ZNGA, FB, GRPN)

Top Analyst Upgrades and Downgrades (ACTV, AGN, BMY, CAG, COP, DUK, LLY, FRX, MRK, PFE, TIF, ULTA, WPI, YUM)

No News is Good News — Peregrine Pharma

Vical Scores Big License Pact with Bristol-Myers Squibb

Top Analyst Upgrades and Downgrades (AU, AAPL, AN, BNS, BMY, CI, CLNE, CMCSA, OFC, DNKN, GFI, HMY, ICE, JCI, JNJ, SQM, FINL, WPI, YELP)

24/7 Wall St. Closing Bell — August 24, 2012: Markets Up on Macro News (BMY, KMI, STX, CPB, SPLS, ARUN, BEBE, CRM, SCVL, SOL, MSG, MDGN, SVU, ADSK)

Top Analyst Upgrades and Downgrades (ANF, AEO, ADSK, BMY, BIP, CPB, DV, IDCC, KMI, MDCO, MRK, OTEX, PCYC, STX, SPLS, VHC)

Gilead Options & New High In Stock Bring Hope For Further Upside

Drug Giants Show Mixed Earnings (BMY, LLY)

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

Which Biotechs Could Be Next M&A Targets (AMLN, BMY, VRTX, CELG, CBST, AMRN, BMRN, VVUS, ARNA, PCYC, AFFX, THRX, RIGL, HGSI, GSK, DNDN)

Prediction: Pfizer Stock Will Double on This Date

SMH ETF Investors: Watch Hyperscaler Capex Guidance at July Earnings Calls

The Average American Has Worked for 6 Employers and 23% Still Have Multiple Old Retirement Accounts, Fidelity’s 2026 Study Finds

Featured Reads

The Average American Has Worked for 6 Employers and 23% Still Have Multiple Old Retirement Accounts, Fidelity's 2026 Study Finds

Fidelity's 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans